Last 48 quarters of trend data · Industrials · Manufacturing - Metal Fabrication
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Proto Labs, Inc.'s quarterly P/E stands at 43.2x, down 26.0% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 118.0% YoY to 32.1x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 92.11 | 43.20 | 50.59 | 41.69 | 55.61 | 58.40 | — | 25.32 | 42.90 | 44.69 | 36.07 | 21.29 | — |
| — | -26.0% | — | +64.7% | +29.6% | +30.7% | — | +18.9% | — | -46.1% | — | -67.3% | — | |
| P/S Ratio | 3.62 | 2.48 | 2.24 | 2.24 | 1.80 | 1.70 | 1.96 | 1.46 | 1.56 | 1.80 | 2.02 | 1.31 | 1.87 |
| — | +46.5% | +14.0% | +52.8% | +15.4% | -5.9% | -2.6% | +11.3% | -16.8% | +2.9% | +34.6% | -36.1% | -27.8% | |
| P/B Ratio | 2.93 | 2.03 | 1.82 | 1.82 | 1.46 | 1.30 | 1.43 | 1.08 | 1.14 | 1.34 | 1.45 | 1.00 | 1.34 |
| — | +55.5% | +27.7% | +68.5% | +27.9% | -2.8% | -1.6% | +7.7% | -14.8% | +3.9% | +46.1% | -18.8% | -16.4% | |
| P/FCF | 32.33 | 19.74 | 36.38 | 9.97 | 26.67 | 12.51 | 14.53 | 5.83 | 19.12 | 12.29 | — | 8.15 | 38.82 |
| — | +57.9% | +150.5% | +71.1% | +39.5% | +1.8% | — | -28.5% | -50.7% | +6.7% | — | -67.0% | +21.4% | |
| EV / EBITDA | 30.37 | 32.10 | 17.60 | 16.03 | 16.17 | 14.73 | 16.86 | 9.31 | 11.56 | 13.09 | 13.11 | 7.89 | 14.31 |
| — | +118.0% | +4.4% | +72.3% | +39.9% | +12.5% | +28.6% | +17.9% | -19.2% | -17.8% | -13.4% | -43.6% | -7.8% | |
| EV / EBIT | 69.56 | — | 34.24 | 27.03 | 33.15 | 32.44 | — | 16.50 | 23.51 | 26.99 | 23.40 | 14.53 | 97.12 |
| — | — | — | +63.9% | +41.0% | +20.2% | — | +13.5% | -75.8% | -35.3% | — | -63.0% | +59.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Proto Labs, Inc.'s operating margin was 7.1% in Q1 2026, up 1.4 pp QoQ and up 3.5 pp YoY. The trailing four-quarter average of 5.8% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 3.4% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5% | 45.6% | 44.2% | 45.3% | 44.3% | 44.1% | 42.7% | 45.6% | 45.0% | 44.9% | 44.6% | 45.4% | 43.4% |
| — | +3.4% | +3.6% | -0.6% | -1.7% | -1.8% | -4.4% | +0.4% | +3.6% | +5.2% | +6.2% | +2.9% | -4.0% | |
| Operating Margin | 4.9% | 7.1% | 5.7% | 6.5% | 3.8% | 3.6% | 3.4% | 6.8% | 4.8% | 5.3% | 6.7% | 8.0% | 4.7% |
| — | +98.4% | +68.8% | -4.3% | -20.6% | -33.3% | -50.1% | -14.5% | +2.3% | +76.1% | +452.4% | +34.0% | -43.0% | |
| Net Margin | 4.0% | 5.8% | 4.4% | 5.3% | 3.3% | 2.9% | -0.3% | 5.7% | 3.6% | 4.1% | 5.6% | 6.1% | -0.3% |
| — | +104.1% | +1424.6% | -6.9% | -9.3% | -30.8% | -105.9% | -6.0% | +1253.5% | +95.0% | +105.6% | +87.5% | -115.5% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.2% | 1.2% | 0.9% | 1.1% | 0.7% | 0.5% | -0.1% | 1.1% | 0.7% | 0.8% | 1.0% | 1.2% | -0.1% |
| — | +120.9% | +1602.2% | +3.1% | +1.3% | -28.8% | -105.9% | -9.5% | +1279.1% | +97.9% | +106.6% | +140.2% | -118.1% | |
| ROA | 2.8% | 1.1% | 0.8% | 1.0% | 0.6% | 0.5% | -0.1% | 1.0% | 0.6% | 0.7% | 0.9% | 1.0% | -0.0% |
| — | +116.9% | +1564.4% | +1.2% | +0.6% | -28.9% | -106.0% | -6.7% | +1317.6% | +104.7% | +106.7% | +135.4% | -117.7% | |
| ROIC | 3.4% | 1.3% | 1.0% | 1.2% | 0.7% | 0.6% | 0.5% | 1.1% | 0.8% | 0.8% | 1.0% | 1.2% | 0.7% |
| — | +125.9% | +98.2% | +7.7% | -11.8% | -31.1% | -49.1% | -13.1% | +12.7% | +91.8% | +584.6% | +74.9% | -33.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Proto Labs, Inc.'s Debt/EBITDA ratio is 0.3x, down from 0.3x last quarter — comfortably within a safe range. The current ratio has improved 12.3% YoY to 3.51x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 |
| — | -19.8% | +32.2% | -39.0% | -34.9% | -33.6% | -33.5% | -79.8% | -78.0% | -76.2% | -74.2% | +321.5% | +332.7% | |
| Debt / EBITDA | 0.08 | 0.27 | 0.29 | 0.14 | 0.21 | 0.24 | 0.27 | 0.23 | 0.30 | 0.31 | 0.31 | 1.03 | 1.34 |
| — | +11.8% | +7.7% | -39.7% | -31.0% | -23.4% | -11.9% | -77.3% | -77.6% | -80.2% | -84.3% | +205.4% | +383.9% | |
| Current Ratio | 3.49 | 3.51 | 3.49 | 3.24 | 3.31 | 3.13 | 3.66 | 3.59 | 4.08 | 3.60 | 4.04 | 2.74 | 2.80 |
| — | +12.3% | -4.7% | -9.9% | -18.9% | -13.0% | -9.4% | +31.1% | +45.8% | +49.6% | +55.0% | -13.5% | -13.6% | |
| Quick Ratio | 3.27 | 3.30 | 3.27 | 3.04 | 3.09 | 2.92 | 3.43 | 3.36 | 3.83 | 3.38 | 3.76 | 2.56 | 2.58 |
| — | +13.2% | -4.6% | -9.7% | -19.3% | -13.7% | -9.0% | +31.5% | +48.6% | +51.9% | +55.8% | -12.7% | -13.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PRLB stock.
Proto Labs, Inc.'s current P/E is 92.1x. The average P/E over the last 4 quarters is 47.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Proto Labs, Inc.'s current operating margin is 4.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Proto Labs, Inc.'s business trajectory between earnings reports.